Protalix BioTherapeutics (PLX) Gross Margin (2010 - 2026)
Protalix BioTherapeutics (PLX) reported Gross Margin of 60.99% for Q2 2026, down 1.52 percentage points from 62.51% a year earlier and down 26.78 percentage points from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Gross Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Protalix BioTherapeutics' Gross Margin came in at 69.20%, up 11.67 percentage points year-over-year; for FY2025, it was 48.82%, down 5.64 percentage points from FY2024.
- Gross Margin has a five-year change of -33.89 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 54.46% in FY2024 (-10.45 pp), 64.91% in FY2023 (+6.04 pp), 58.87% in FY2022 (+1.50 pp) and 57.37% in FY2021 (-25.34 pp).
- Five-year quarterly Gross Margin spans a low of 15.54% in Q4 2023 and a high of 87.77% in Q1 2026.
- Year over year, Gross Margin gained in four of the last eight quarters, with an average year-over-year change of +15.36 percentage points.
- The high point for year-over-year Gross Margin in five years was Q1 2026 (a gain of 68.66 percentage points); the low point was Q4 2023 (a drop of 56.64 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 87.77% (Q1 2026), 49.36% (Q4 2025) and 53.37% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 72.78% |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn | 60.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.99% |
| Mar 31, 2026 | 87.77% |
| Dec 31, 2025 | 49.36% |
| Sep 30, 2025 | 53.37% |
| Jun 30, 2025 | 62.51% |
| Mar 31, 2025 | 19.11% |
| Dec 31, 2024 | 78.67% |
| Sep 30, 2024 | 53.37% |
| Jun 30, 2024 | 29.82% |
| Mar 31, 2024 | 30.58% |
| Dec 31, 2023 | 15.54% |
| Sep 30, 2023 | 52.70% |
| Jun 30, 2023 | 82.47% |
| Mar 31, 2023 | 67.82% |
| Dec 31, 2022 | 72.18% |
| Sep 30, 2022 | 50.12% |
| Jun 30, 2022 | 53.31% |
| Mar 31, 2022 | 62.49% |
| Dec 31, 2021 | 63.18% |
| Sep 30, 2021 | 69.28% |
API Access
Protalix BioTherapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();